Apolipoprotein A I (APOA1) Goat Polyclonal Antibody
Specifications
Product Data | |
Applications | ELISA, IHC, IP, WB |
Recommended Dilution | Anti-Apolipoprotein antibodies have been used for Indirect trapping ELISA for quantitation of antigen in serum using a standard curve, for Immunoprecipitation and for Western blotting for highly sensitive qualitative analysis. Recommended Dilutions: ELISA: 1/10,000-1/20,000. Western blot: 1/1,000-1/2,000. Immunoprecipitation: 1/100. Immunohistochemistry: 1/50-1/200. |
Reactivities | Human |
Host | Goat |
Clonality | Polyclonal |
Immunogen | Apolipoprotein Type A-I was isolated from Human plasma by density gradient centrifugation followed by HPLC purification. |
Specificity | Typically less than 1% cross reactivity against other types of Apolipoprotein was detected by ELISA against purified standards. This antibody reacts with Human Apolipoprotein A-I and has negligible cross-reactivity with Type A-II, B, C-I, C-II, C-III, E and J Apolipoproteins. Non-specific cross reaction of anti-Apolipoprotein antibodies with other Human serum proteins is negligible. |
Formulation | 0.125M Sodium Borate, 0.075M Sodium Chloride, 0.005M EDTA, pH 8.0 State: Purified State: Liquid (sterile filtered) purified IgG fraction Stabilizer: None Preservative: 0.01% Sodium Azide |
Concentration | lot specific |
Purification | Immunoaffinity Chromatography using immobilized antigens followed by extensive cross-adsorption against other Apolipoproteins and human serum proteins to remove any unwanted specificities. |
Storage | Store vial at 2-8°C prior to opening. This product is stable at 2-8°C as an undiluted liquid. For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Dilute only prior to immediate use. |
Stability | Shelf life: one year from despatch. |
Database Link | |
Background | Apolipoprotein A I promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A I is the major protein component of high density lipoprotein (HDL) in the plasma. Synthesized in the liver and small intestine, it consists of two identical chains of 77 amino acids; an 18 amino acid signal peptide is removed co-translationally and a 6 amino acid propeptide is cleaved post-translationally. Apolipoprotein A I is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases. |
Synonyms | APOA1, ApoA-I, Apo-AI, ApoAI |
Reference Data |
Documents
Product Manuals |
FAQs |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.